PathosLogos Inc.
PrivateLast Round
Series B
Mar 31, 2026
Est. Valuation
$108.24M
Total Funding Raised
$53.56M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PathosLogos Inc. operates in Enterprise Software and is based in Tokyo. Its latest recorded funding round was a Series B round in March 2026.
PathosLogos Inc. is an enterprise software company that provides an integrated HR co-creation platform and payroll SaaS solutions for large enterprises.
Sector
Enterprise Software
Verticals
HR, Data Integration, Enterprise Resource Planning
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathosLogos Inc. Comparables
Compare PathosLogos Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Works Human Intelligence Co., Ltd. | 82% | |
| SmartHR | 79% | |
| HRBrain | 76% |
For institutional investors. Book with your work email.
PathosLogos Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Jul 19, 2024 | ||||
| Seed | Oct 31, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PathosLogos Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GLOBIS Capital Partners | Series A |
| THE GOGIN CAPITAL Co., Ltd. | Series B |
| JAFCO Group Co., Ltd. | Series A |
| Rheos Capital Partners | Series B |
| Mizuho Capital | Series B |
| Salesforce Ventures | Series B |
| Chibagin Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 80, 178% of headcount.
- Jul 20, 2026
Open roles increased to 80, 178% of headcount.
For institutional investors. Book with your work email.
PathosLogos Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PathosLogos Inc.'s valuation, stock price, and market status.
Is PathosLogos Inc. a public or private company?
PathosLogos Inc. is a private company.
What is the current stock price of PathosLogos Inc.?
PathosLogos Inc. is a private company, so its shares have no public market price. Caplight tracks PathosLogos Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PathosLogos Inc. worth (valuation)?
PathosLogos Inc.'s valuation is estimated at $108.2M based on funding round data.
Can I buy PathosLogos Inc. stock?
PathosLogos Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PathosLogos Inc.'s last funding round?
PathosLogos Inc.'s most recent funding round was Series B on March 31, 2026.
Who are the main investors in PathosLogos Inc.?
Key investors in PathosLogos Inc. include GLOBIS Capital Partners, Rheos Capital Partners, Rheos Capital Partners, SBI Investment Co., Ltd..
Will PathosLogos Inc. IPO soon?
No public IPO plans have been announced for PathosLogos Inc..
How can I track PathosLogos Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PathosLogos Inc.'s shares on secondary markets.